Predictors of functional outcome after thrombectomy for M2 occlusions: a large scale experience from clinical practice

被引:4
|
作者
Kniep, Helge [1 ]
Meyer, Lukas [1 ]
Broocks, Gabriel [1 ]
Bechstein, Matthias [1 ]
Guerreiro, Helena [1 ]
Winkelmeier, Laurens [1 ]
Brekenfeld, Caspar [1 ]
Flottmann, Fabian [1 ]
Deb-Chatterji, Milani [2 ]
Alegiani, Anna [2 ,3 ]
Hanning, Uta [1 ]
Thomalla, Goetz [2 ]
Fiehler, Jens [1 ]
Gellissen, Susanne [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Diag & Intervent Neuroradiol, Martini Str 52, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany
[3] Asklepios Klin Altona, Dept Neurol, Hamburg, Germany
关键词
ACUTE ISCHEMIC-STROKE; ENDOVASCULAR TREATMENT; BLOOD-GLUCOSE;
D O I
10.1038/s41598-023-45232-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mechanical thrombectomy (MT) for acute ischemic stroke with medium vessel occlusions is still a matter of debate. We sought to identify factors associated with clinical outcome after MT for M2-occlusions based on data from the German Stroke Registry-Endovascular Treatment (GSR-ET). All patients prospectively enrolled in the GSR-ET from 05/2015 to 12/2021 were analyzed (NCT03356392). Inclusion criteria were primary M2-occlusions and availability of relevant clinical data. Factors associated with excellent/good outcome (modified Rankin scale mRS 0-1/0-2), poor outcome/death (mRS 5-6) and mRS-increase pre-stroke to day 90 were determined in multivariable logistic regression. 1348 patients were included. 1128(84%) had successful recanalization, 595(44%) achieved good outcome, 402 (30%) had poor outcome. Successful recanalization (odds ratio [OR] 4.27 [95% confidence interval 3.12-5.91], p<0.001), higher Alberta stroke program early CT score (OR 1.25 [1.18-1.32], p<0.001) and i.v. thrombolysis (OR 1.28 [1.07-1.54], p<0.01) increased probability of good outcome, while age (OR 0.95 [0.94-0.95], p<0.001), higher pre-stroke-mRS (OR 0.36 [0.31-0.40], p<0.001), higher baseline NIHSS (OR 0.89 [0.88-0.91], p<0.001), diabetes (OR 0.52 [0.42-0.64], p<0.001), higher number of passes (OR 0.75 [0.70-0.80], p<0.001) and intracranial hemorrhage (OR 0.26 [0.14-0.46], p<0.001) decreased the probability of good outcome. Additional predictors of mRS-increase pre-stroke to 90d were dissections, perforations (OR 1.59 [1.11-2.29], p<0.05) and clot migration, embolization (OR 1.67 [1.21-2.30], p<0.01). Corresponding to large-vessel-occlusions, younger age, low pre-stroke-mRS, low severity of acute clinical disability, i.v. thrombolysis and successful recanalization were associated with good outcome while diabetes and higher number of passes decreased probability of good outcome after MT in M2 occlusions. Treatment related complications increased probability of mRS increase pre-stroke to 90d.
引用
收藏
页数:10
相关论文
共 47 条
  • [41] Improving the Objective Quality of Large-Scale Clinical Trials for Women With Heavy Menstrual Bleeding: Experience from 2 Multi-Center, Randomized Trials
    Fraser, Ian S.
    Zeun, Susan
    Parke, Susanne
    Wilke, Baerbel
    Junge, Wolfgang
    Serrani, Marco
    REPRODUCTIVE SCIENCES, 2013, 20 (07) : 745 - 754
  • [42] Improving the Objective Quality of Large-Scale Clinical Trials for Women With Heavy Menstrual Bleeding: Experience from 2 Multi-Center, Randomized Trials
    Ian S. Fraser
    Susan Zeun
    Susanne Parke
    Baerbel Wilke
    Wolfgang Junge
    Marco Serrani
    Reproductive Sciences, 2013, 20 : 745 - 754
  • [43] Psychological and Situational Factors Affecting Dropout from Regular Visits in Diabetes Practice: The Japan Diabetes Outcome Intervention Trial-2 Large Scale Trial 004 (J-DOIT2-LT004)
    Kabeya, Yusuke
    Goto, Atsushi
    Hayashino, Yasuaki
    Suzuki, Hikari
    Furukawa, Toshi A.
    Yamazaki, Katsuya
    Izumi, Kazuo
    Noda, Mitsuhiko
    JMA JOURNAL, 2022, 5 (04): : 427 - 437
  • [44] Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study
    Degli Esposti, Luca
    Perrone, Valentina
    Veronesi, Chiara
    Gambera, Marco
    Nati, Giulio
    Perone, Francesco
    Tagliabue, Paola Fausta
    Buda, Stefano
    Borghi, Claudio
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (09) : 1571 - 1577
  • [45] Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR&lt;45 mL/min/1.73 m2): a summary document from the European Renal Best Practice Group
    Farrington, Ken
    Covic, Adrian
    Nistor, Ionut
    Aucella, Filippo
    Clyne, Naomi
    De Vos, Leen
    Findlay, Andrew
    Fouque, Denis
    Grodzicki, Tomasz
    Iyasere, Osasuyi
    Jager, Kitty J.
    Joosten, Hanneke
    Macias, Juan Florencio
    Mooney, Andrew
    Nagler, Evi
    Nitsch, Dorothea
    Taal, Maarten
    Tattersall, James
    Stryckers, Marijke
    van Asselt, Dieneke
    Van den Noortgate, Nele
    van der Veer, Sabine
    van Biesen, Wim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (01) : 9 - 16
  • [46] Analysis of functional outcome after posttraumatic thumb reconstruction in comparison to nonreconstructed amputated thumbs at the proximal phalanx of the thumb ray: A mid-term follow-up with special attention to the Manchester-modified M2 DASH questionnaire and effect size of Cohen's d
    Parvizi, Daryousch
    Koch, Horst
    Friedl, Herwig
    Spendel, Stephan
    Hubmer, Martin
    Parvizi, Irene
    Prandl, Eva
    Rappl, Thomas
    Haas, Franz
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 72 (02): : E33 - E40
  • [47] Comparable survival in newly diagnosed multiple myeloma (MM) after VAD induction with high dose therapy using melphalan 140mg/m2 + TBI 12 Gy (MEL+TBI) versus standard therapy with VBMCP and no benefit from interferon (IFN) maintenance:: Final clinical results of intergroup trial S9321 in the context of IFM 90 and MRC VII trials.
    Crowley, J
    Fonseca, R
    Greipp, P
    McCoy, J
    Barlogie, B
    BLOOD, 2004, 104 (11) : 156A - 157A